Reudelhuber T L, Ramla D, Chiu L, Mercure C, Seidah N G
Laboratory of Molecular Biochemistry of Hypertension, Clinical Research Institute of Montreal, Quebec, Canada.
Kidney Int. 1994 Dec;46(6):1522-4. doi: 10.1038/ki.1994.435.
Previous studies have demonstrated that the mouse proprotein convertase PC1 (mPC1) accurately cleaves human prorenin to generate active renin and that this processing event appears to require co-packaging in secretory granules. In the current study, we have tested human PC1 (hPC1; also called PC3) for its ability to activate human prorenin. Our results suggest that while hPC1 is capable of carrying out the specific cleavage of human prorenin, it does so at a reduced efficiency as compared to mPC1. This difference is due to sequences in the carboxy-terminus of PC1 as demonstrated by the activity of hybrid hPC1/mPC1 molecules. These studies demonstrate that PC1 cleavage of prorenin can occur in humans and identify a functionally important region in the hPC1 protein for this interaction. Moreover, the localization of PC1 in human tissues suggests that it may participate in the generation of active renin in the adrenal medulla and possibly in certain adrenal tumors.
先前的研究表明,小鼠前蛋白转化酶PC1(mPC1)能准确切割人肾素原以产生活性肾素,并且这一加工过程似乎需要共包装于分泌颗粒中。在本研究中,我们测试了人PC1(hPC1;也称为PC3)激活人肾素原的能力。我们的结果表明,虽然hPC1能够对人肾素原进行特异性切割,但与mPC1相比,其切割效率较低。如杂交hPC1/mPC1分子的活性所示,这种差异是由于PC1羧基末端的序列所致。这些研究表明,人肾素原的PC1切割可在人体中发生,并确定了hPC1蛋白中这一相互作用的功能重要区域。此外,PC1在人体组织中的定位表明,它可能参与肾上腺髓质以及某些肾上腺肿瘤中活性肾素的生成。